Allogene Therapeutics, Inc. (ALLO) vs Delcath Systems, Inc. (DCTH)
A side-by-side comparison of Allogene Therapeutics, Inc. and Delcath Systems, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALLO
Allogene Therapeutics, Inc.
$1.47HealthcareDelayed quote: Oct 6, 2026, 10:10 AM EDT
DCTH
Delcath Systems, Inc.
$15.56HealthcareDelayed quote: Oct 6, 2026, 10:10 AM EDT
Total return — ALLO vs DCTH
growth of $100 · dividends reinvested · last 8yALLO -94.0% (-29.6%/yr)DCTH -98.0% (-38.8%/yr)ALLO compounded faster over this window
ALLO DCTH
ALLO vs DCTH: by the numbers
- •DCTH is the larger company ($537M vs $507M market cap).
- •DCTH is profitable (0.56% net margin) while ALLO runs a net loss (-3566.68%).
- •DCTH grew revenue faster over the past five years (118.96% vs -34.47% CAGR).
Metrics side by side
Valuation
| Metric | ALLO | DCTH |
|---|---|---|
| P/E ratio | N/A | 1196.92 |
| P/S ratio | 109.35 | 5.63 |
| P/B ratio | 1.16 | 4.43 |
| FCF yield | N/A | 3.26% |
Profitability
| Metric | ALLO | DCTH |
|---|---|---|
| Gross margin | 0.00% | 87.05% |
| Operating margin | 0.00% | -1.90% |
| Net margin | -3566.68% | 0.56% |
| ROE | -37.94% | 0.44% |
| ROIC | -34.79% | -0.81% |
Growth (annualized)
| Metric | ALLO | DCTH |
|---|---|---|
| Revenue CAGR (5Y) | -34.47% | 118.96% |
| Total return CAGR (5Y) | -42.72% | 10.90% |
Frequently asked
- Which has grown faster, ALLO or DCTH?
- Over the past five years, DCTH grew revenue faster — ALLO at a -34.47% CAGR versus DCTH at 118.96%.
- Is ALLO or DCTH more profitable?
- DCTH runs the higher net margin — ALLO at -3566.68% versus DCTH at 0.56%.
- How have ALLO and DCTH total returns compared?
- Over the past 5 years, ALLO delivered -42.72% and DCTH delivered 10.90% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Delcath Systems P/E ratioAllogene Therapeutics ROEDelcath Systems ROEAllogene Therapeutics operating marginDelcath Systems operating marginAllogene Therapeutics revenue growthDelcath Systems revenue growthAllogene Therapeutics free cash flowDelcath Systems free cash flow
Allogene Therapeutics & Delcath Systems appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.